Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
In addition, we queried the PhenoScanner online platform to determine whether any IVs were associated with BMI, vitamin D, smoking, or MS.
Source: Sensitivity analysis and confounding analysis. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Genetic instrumental-variable study.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Causal effects of gut microbiota on multiple sclerosis: A two‐sample Mendelian randomization study
Source: Article title.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Causal effects of gut microbiota on multiple sclerosis: A two‐sample Mendelian randomization study
Genetic instrumental-variable study · Brain and Behavior · 2024
Original publication title
Causal effects of gut microbiota on multiple sclerosis: A two‐sample Mendelian randomization study
© 2024 The Author(s). Brain and Behavior published by Wiley Periodicals LLC.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
We performed a Mendelian randomization study (MR) to assess the causal effects of gut microbiota on MS.
Source: ObjectiveAbstract: What methods does the paper describe?
Independent genetic variants associated with 211 gut microbiota phenotypes were selected as instrumental variables from the largest genome‐wide association studies (GWAS) previously published by the MiBioGen study. GWAS data for MS were obtained from the International Multiple Sclerosis Genetics Consortium (IMSGC) for primary analysis and the FinnGen consortium for replication and collaborative analysis. Sensitivity analyses were conducted to evaluate heterogeneity and pleiotropy.
Source: MethodsAbstract: Results
After inverse‐variance‐weighted and sensitivity analysis filtering, seven gut microbiota with potential causal effects on MS were identified from the IMSGC. Only five metabolites remained significant associations with MS when combined with the FinnGen consortium, including genus Anaerofilum id.2053 (odds ratio [OR] = 1.141, 95% confidence interval [CI]: 1.021 to 1.276, p = .021), Ruminococcus2 id.11374 (OR = 1.190, 95% CI: 1.007 to 1.406, p = .042), Ruminococcaceae UCG003 id.11361 (OR = 0.822, 95% CI: 0.688 to 0.982, p = .031), Ruminiclostridium5 id.11355 (OR = 0.724, 95% CI: 0.585 to 0.895, p = .003), Anaerotruncus id.2054 (OR = 0.772, 95% CI: 0.634 to 0.940, p = .010).
Source: ResultsAbstract: Conclusion
Our MR analysis reveals a potential causal relationship between gut microbiota and MS, offering promising avenues for advancing mechanistic understanding and clinical investigation of microbiota‐mediated MS.
Source: ConclusionAuthors’ abstract
Abstract
Background
Gut microbiota alterations in multiple sclerosis (MS) patients have been reported in observational studies, but whether these associations are causal is unclear.
Objective
We performed a Mendelian randomization study (MR) to assess the causal effects of gut microbiota on MS.
Methods
Independent genetic variants associated with 211 gut microbiota phenotypes were selected as instrumental variables from the largest genome‐wide association studies (GWAS) previously published by the MiBioGen study. GWAS data for MS were obtained from the International Multiple Sclerosis Genetics Consortium (IMSGC) for primary analysis and the FinnGen consortium for replication and collaborative analysis. Sensitivity analyses were conducted to evaluate heterogeneity and pleiotropy.
Results
After inverse‐variance‐weighted and sensitivity analysis filtering, seven gut microbiota with potential causal effects on MS were identified from the IMSGC. Only five metabolites remained significant associations with MS when combined with the FinnGen consortium, including genus Anaerofilum id.2053 (odds ratio [OR] = 1.141, 95% confidence interval [CI]: 1.021 to 1.276, p = .021), Ruminococcus2 id.11374 (OR = 1.190, 95% CI: 1.007 to 1.406, p = .042), Ruminococcaceae UCG003 id.11361 (OR = 0.822, 95% CI: 0.688 to 0.982, p = .031), Ruminiclostridium5 id.11355 (OR = 0.724, 95% CI: 0.585 to 0.895, p = .003), Anaerotruncus id.2054 (OR = 0.772, 95% CI: 0.634 to 0.940, p = .010).
Conclusion
Our MR analysis reveals a potential causal relationship between gut microbiota and MS, offering promising avenues for advancing mechanistic understanding and clinical investigation of microbiota‐mediated MS.
Publication and source details
Original title: Causal effects of gut microbiota on multiple sclerosis: A two‐sample Mendelian randomization study
Dongren Sun; Yangyang Zhang; Rui Wang; Qin Du; Ziyan Shi; Hongxi Chen; Xiaofei Wang; Hongyu Zhou
Brain and Behavior · 2024
* CorrespondenceXiaofei Wang and Hongyu Zhou, Department of Neurology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Email: 417734668@qq.com and zhouhy@scu.edu.cn
© 2024 The Author(s). Brain and Behavior published by Wiley Periodicals LLC.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.Department of Science and Technology of Sichuan Province2022YFS03151·3·5 project for disciplines of excellence: Clinical Research Incubation Project, West China Hospital, Sichuan University21HXFH041National Natural Science Foundation of China 10.13039/50110000180982201494Natural Science Foundation of Sichuan Province 10.13039/5011000185422022NSFSC1432
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T11:11:43.733189+00:00
DOI: 10.1002/brb3.3593 · PMC11186842